30 results on '"Bradley, John"'
Search Results
2. Serotype 19A is the most common serotype causing invasive pneumococcal infections in children
- Author
-
Kaplan, Sheldon L., Barson, William J., Lin, Philana L., Stovall, Stephanie H., Bradley, John S., Tan, Tina Q., Hoffman, Jill A., Givner, Laurence B., and Mason, Edward O., Jr.
- Subjects
Pneumococcal infections -- Diagnosis ,Pneumococcal infections -- Causes of ,Pneumococcal infections -- Demographic aspects ,Pneumococcal infections -- Research ,Streptococcus pneumoniae -- Genetic aspects ,Streptococcus pneumoniae -- Identification and classification ,Pneumococcal vaccine -- Dosage and administration ,Pneumococcal vaccine -- Research ,Serology -- Research - Published
- 2010
3. A prospective, multicenter study of caspofungin for the treatment of documented candida or aspergillus infections in pediatric patients
- Author
-
Zaoutis, Theoklis E., Jafri, Hasan S., Huang, Li-Min, Locatelli, Franco, Barzilai, Asher, Ebell, Wolfram, Steinbach, William J., Bradley, John, Lieberman, Jay M., Hsiao, Chih-Cheng, Seibel, Nita, Laws, Hans-Juergen, Gamba, Melinda, Petrecz, Maria, Taylor, Arlene F., Strohmaier, Kim M., Chow, Joseph W., Kartsonis, Nicholas A., and Ngai, Angela L.
- Subjects
Infectious Diseases Society of America -- Standards ,Caspofungin -- Usage ,Caspofungin -- Health aspects ,Aspergillus -- Care and treatment ,Candida -- Research ,Candida -- Health aspects ,Children -- Diseases ,Children -- Research ,Children -- Care and treatment - Published
- 2009
4. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine
- Author
-
Kaplan, Sheldon L., Mason, Edward O., Jr., Wald, Ellen R., Schutze, Gordon E., Bradley, John S., Tan, Tina Q., Hoffman, Jill A., Givner, Laurence B., Yogev, Ram, and Barson, William J.
- Abstract
Objective. To monitor clinical and microbiologic features including antimicrobial susceptibility and serogroup distribution of invasive infections caused by Streptococcus pneumoniae among children before and after the introduction of routine administration of the 7-valent pneumococcal conjugate vaccine (PCV7). Design. A 9-year (January 1, 1994 through December 31, 2002) prospective surveillance study of all invasive pneumococcal infections in children. Patients. Infants and children cared for at 8 children's hospitals in the United States with culture-proven invasive infections caused by S pneumoniae. Results. When compared with the mean of the years 1994 to 2000, the annual number of invasive pneumococcal infections for children [less than or equal to] 24 months of age declined 58% in 2001 and 66% in 2002. If only the serogroups in the PCV7 are considered, the number of cases in children [less than or equal to] 24 months old declined 63% and 77% in 2001 and 2002, respectively. The greatest decrease was observed for serogroup-14 isolates. The number of isolates in nonvaccine serogroups increased 28% in 2001 and 66% in 2002 for children [less than or equal to] 24 months old. Nonvaccine serogroup-15 and -33 isolates had the greatest increase in number. The proportion of all isolates nonsusceptible to penicillin increased yearly from 1994 to 2000, reached a plateau in 2001 at 45%, and declined to 33% in 2002. Decrease in nonsusceptibility to penicillin occurred entirely in the isolates with penicillin minimum inhibitory concentration [greater than or equal to] 2 [micro]g/mL. Nonsusceptibility to penicillin increased slightly among nonvaccine-serotype isolates. Most infections after at least 2 doses of PCV7 were caused by nonvaccine-serotype isolates. Conclusions. Since the introduction of the PCV7, the number of invasive pneumococcal infections caused by vaccine-serogroup isolates among 8 US children's hospitals has decreased >75% among children [less than or equal to] 24 months old. In addition, penicillin resistance decreased in 2002 for the first time since our surveillance began in 1993-1994. However, we have noted that replacement may be developing with serogroups 15 and 33. Furthermore, penicillin resistance seems to be increasing among nonvaccine serogroups. Surveillance must be continued to detect the emergence of changes in the distribution of serotypes as well as antibiotic susceptibility. Pediatrics 2004;113:443-449; Streptococcus pneumoniae, conjugate vaccine, surveillance. ABBREVIATIONS. PCV7, 7-valent pneumococcal conjugate vaccine; CDC, Centers for Disease Control and Prevention; ABC, Active Bacterial Core; HIV, human immunodeficiency virus., In the United States, Streptococcus pneumoniae has long been the most common organism associated with bacteremia and bacterial pneumonia in children. It became the most common cause of bacterial meningitis [...]
- Published
- 2004
5. Streptococcus pneumoniae infections in the neonate
- Author
-
Hoffman, Jill A., Mason, Edward O., Schutze, Gordon E., Tan, Tina Q., Barson, William J., Givner, Laurence B., Wald, Ellen R., Bradley, John S., Yogev, Ram, and Kaplan, Sheldon L.
- Abstract
Objective. Streptococcus pneumoniae infections in the neonate (SPIN) are relatively unusual events (1%-11% of neonatal sepsis) but are associated with substantial morbidity and mortality. Previous reports suggest that invasive SPIN is associated with prolonged rupture of membranes, maternal colonization/illness, prematurity, early-onset pneumonia presentation ( Methods. The US Pediatric Multicenter Pneumococcal Surveillance Group has been prospectively monitoring S pneumoniae infections since 1993 in 8 children's hospitals. For this report, data were gathered retrospectively from the charts of neonates who were 30 days of age and younger and had SPIN from September 1993 to February 2001. All pneumococcal isolates were sent to a central laboratory for serogrouping/typing and susceptibility testing. Results. Twenty-nine cases of SPIN were identified from a total of 4428 episodes of S pneumoniae infection in children. Sixty-six percent were male, and 55% were white; the mean age was 18.1 day ([+ or -] 8.2). Ninety percent of infants were [greater than or equal to] 38 weeks' gestation. Two mothers had bacterial infections at delivery; 1 had S pneumoniae isolated from both blood and cervix, and 1 had clinical amnionitis. The primary diagnoses in the neonates were bacteremia (8), meningitis (8), bacteremic pneumonia (4), septic arthritis/osteomyelitis (1), and otitis media (8). Thirty percent of infants with invasive SPIN presented with leukopenia/neutropenia, but this did not predict poor outcome. The infecting pneumococcal serogroups were 19 (32%); 9 (18%); 3 and 18 (11% each); 1, 6, and 14 (7% each); and 5 and 12 (3.5% each). Twenty-six percent of invasive neonatal infections were caused by serogroups 1, 3, 5, and 12, which are not contained in the heptavalent pneumococcal vaccine. In contrast, 6% of invasive nonneonatal disease was caused by these same nonvaccine serogroups. Susceptibility testing demonstrated that 21.4% of isolates were penicillin nonsusceptible and 3.6% were ceftriaxone nonsusceptible. Three (14.3%) neonates with invasive SPIN died; all deaths occurred within 36 hours of presentation. Deaths did not appear to be related to pneumococcal serogroup or susceptibilities. Conclusions. Compared with previous studies of neonates with pneumococcal infection, this series showed that infants with SPIN were usually 2 to 3 weeks of age at presentation; likely to be full term; and ill with pneumonia, meningitis, and otitis media. This late-onset presentation was associated with an overall mortality rate of 10.3% (14.3% for invasive disease). Pediatrics 2003;112: 1095-1102; Streptococcus pneumoniae, neonates, risk factors., ABBREVIATIONS. PCV7, heptavalent pneumococcal conjugate vaccine; SPIN, Streptococcus pneumoniae infections in the neonate; GBS, group B Streptococcus; PROM, prolonged rupture of membranes; GA, gestational age; LBW, low birth weight; S, [...]
- Published
- 2003
6. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae
- Author
-
Tan, Tina Q., Mason, Edward O., Jr, Wald, Ellen R., Barson, William J., Schutze, Gordon E., Bradley, John S., Givner, Laurence B., Yogev, Ram, Kim, Kwang Sik, and Kaplan, Sheldon L.
- Subjects
Pneumonia, Pneumococcal -- Health aspects ,Streptococcus pneumoniae -- Health aspects - Abstract
Objective. The frequency of children who are hospitalized with pneumococcal pneumonia complicated by necrosis, empyema/complicated parapneumonic effusion, and lung abscess seems to be increasing. The factors that contribute to this increase are unclear; therefore, the objective of this study was to describe and compare the relative frequency, clinical characteristics, and outcome of hospitalized children with complicated pneumonia with those of children with uncomplicated pneumonia caused by Streptococcus pneumoniae in the era of antibiotic resistance. Methods. A multicenter, retrospective study of 8 children's hospitals in the United States was undertaken. A total of 368 children who were hospitalized with pneumococcal pneumonia identified from patients enrolled in the US Pediatric Multicenter Pneumococcal Surveillance Study over the period from September 1, 1993, to January 31, 2000 were studied. Demographic and clinical variables, antibiotic susceptibility, pneumococcal serotypes, antimicrobial therapy, and clinical outcome in hospitalized children with complicated versus uncomplicated pneumococcal pneumonia were measured. Results. A total of 368 patients with pneumococcal pneumonia were identified. Of the 368 isolates, 47 (12.8%) were intermediate and 37 (10.1%) were resistant to penicillin; 18 (5%) were intermediate to ceftriaxone, and 9 (2.5%) were resistant to ceftriaxone. A total of 133 patients met the criteria for complicated pneumonia and had a chest tube placed; 56 of these patients subsequently underwent decortication. The proportion of hospitalized patients with complicated pneumococcal pneumonia increased progressively over the study period from 22.6% in 1994 to 53% in 1999. Patients with complicated disease were older (median age: 45 vs 27 months) and significantly more likely to be of white race and have chest pain on presentation compared with patients with uncomplicated disease. Patients who had complicated disease and underwent decortication were more likely to have pleural fluid lactate dehydrogenase levels of >7500 IU/L compared with those patients who had chest tube placement alone. Fifty-three percent of children who were [greater than or equal to] 61 months of age and were hospitalized had complicated pneumonia. This group of children accounted overall for 42% of the patients with complicated pneumonia, 48.2% of the patients who subsequently underwent decortication, and 44% of the patients who had received a course of antibiotics before diagnosis. Pneumococcal serotypes 1, 6, 14, and 19 were the most prevalent serotypes causing disease, with serotype 1 causing 24.4% of the complicated cases versus 3.6% of the uncomplicated cases. Ninety-eight percent of the patients in both groups recovered from their pneumonia. Antibiotic resistance was not found to be more prevalent in those patients with complicated disease. Conclusions. The relative frequency of complicated disease in hospitalized children with pneumococcal pneumonia is increasing. Patients with complicated pneumococcal disease were older and significantly more likely to be of white race compared with those patients with uncomplicated disease. Pneumococcal serotype 1 caused significantly more disease in patients with complicated versus uncomplicated pneumonia. Patients with complicated disease were not more likely to be infected with an antibiotic-resistant isolate. Pediatrics 2002;110: 1-6; pneumococcal pneumonia, complicated pneumonia, pediatrics., Streptococcus pneumoniae is the most common bacterial pathogen that causes community-acquired pneumonia in both adults and children, accounting for an estimated 550 000 cases of pneumonia each year. (1-3) During [...]
- Published
- 2002
7. Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment
- Author
-
Kanegaye, John T., Soliemanzadeh, Peyman, and Bradley, John S.
- Subjects
Meningitis -- Drug therapy ,Spine -- Puncture - Abstract
Objective. Despite the lack of evidence defining a time interval during which cerebrospinal fluid (CSF) culture yield will not be affected by previous antibiotic therapy, recent publications cite a "minimum window" of 2 to 3 hours for recovery of bacterial pathogens after parenteral antibiotic administration. We conducted a retrospective review of children with bacterial meningitis to describe the rate at which parenteral antibiotic pretreatment sterilizes CSF cultures. Methods. The medical records of pediatric patients who were discharged from a tertiary children's hospital during a 5-year period with the final diagnosis of bacterial meningitis or suspected bacterial meningitis were reviewed. The decay in yield of CSF cultures over time was evaluated in patients with lumbar punctures (LP) delayed until after initiation of parenteral antibiotics and in patients with serial LPs before and after initiation of parenteral antibiotics. Results. The pathogens that infected the 128 study patients were Streptococcus pneumoniae (49), Neisseria meningitidis (37), group B Streptococcus (21), Haemophilus influenzae (8), other organisms (11), and undetermined (3). Thirty-nine patients (30%) had first LPs after initiation of parenteral antibiotics, and 55 (43%) had serial LPs before and after initiation of parenteral antibiotics. After [greater than or equal to] 50 mg/kg of a third-generation cephalospotin, 3 of 9 LPs in meningococcal meningitis were sterile within 1 hour, occurring as early as 15 minutes, and all were sterile by 2 hours. With pneumococcal disease, the first negative CSF culture occurred at 4.3 hours, with 5 of 7 cultures negative from 4 to 10 hours after initiation of parenteral antibiotics. Reduced susceptibility to [beta]-lactam antibiotics occurred in 11 of 46 pneumococcal isolates. Group B streptococcal cultures were positive through the first 8 hours after parenteral antibiotics. Blood cultures were positive in 74% of cases without pretreatment and in 57% to 68% of cases with negative CSF cultures. Conclusions. The temptation to initiate antimicrobial therapy may override the principle of obtaining adequate pretreatment culture material. The present study demonstrates that CSF sterilization may occur more rapidly after initiation of parenteral antibiotics than previously suggested, with complete sterilization of meningococcus within 2 hours and the beginning of sterilization of pneumococcus by 4 hours into therapy. Lack of adequate culture material may result in inability to tailor therapy to antimicrobial susceptibility or in unnecessarily prolonged treatment if the clinical presentation and laboratory data cannot exclude the possibility of bacterial meningitis. Pediatrics 2001;108:1169-11/4; bacterial meningitis, spinal puncture, cerebrospinal fluid, diagnostic techniques and procedures, time factors, pneumococcal meningitis, microbial sensitivity test., ABBREVIATIONS. CSF, cerebrospinal fluid; LP, lumbar puncture; CSF WBC, cerebrospinal fluid leukocyte concentration; ED, emergency department; MIC, minimum inhibitory concentration; LPd, delayed LP group; LPp, prior LP group; LPp/p, LP [...]
- Published
- 2001
8. Pediatric pneumococcal bone and joint infections
- Author
-
Bradley, John S., Kaplan, Sheldon L., Tan, Tina Q., Barson, William J., Arditi, Moshe, Schutze, Gordon E., Wald, Ellen R., Givner, Laurence B., and Mason, Edward O.
- Subjects
Pneumonia, Pneumococcal -- Complications and side effects ,Infectious bone diseases -- Risk factors ,Infectious bone diseases -- Development and progression ,Infectious bone diseases -- Care and treatment ,Children -- Diseases ,Children -- Risk factors ,Children -- Development and progression ,Children -- Care and treatment - Abstract
ABSTRACT. Objective. To describe the clinical and microbiological characteristics of infants and children with bone and joint infections caused by penicillin-susceptible and penicillin-nonsusceptible strains of Streptococcus pneumoniae. Design. Multicenter, prospective [...]
- Published
- 1998
9. Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae
- Author
-
Tan, Tina Q., Mason, Edward O., Jr., Barson, William J., Wald, Ellen R., Schutze, Gordon E., Bradley, John S., Arditi, Moshe, Givner, Laurence B., Yogev, Ram, Kim, Kwang Sik, and Kaplan, Sheldon L.
- Subjects
Pneumonia in children -- Patient outcomes ,Pneumonia in children -- Care and treatment - Abstract
ABSTRACT. Objective. To compare the clinical characteristics, treatment, and outcome of pediatric patients with pneumonia attributable to isolates of Streptococcus pneumoniae that were either susceptible or nonsusceptible to penicillin. Design. [...]
- Published
- 1998
10. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use
- Author
-
Arditi, Moshe, Mason, Edward O., Jr., Bradley, John S., Tan, Tina Q., Barson, William J., Schutze, Gordon E., Wald, Ellen R., Givner, Laurence B., Kim, Kwang Sik, Yogev, Ram, and Kaplan, Sheldon L.
- Subjects
Meningitis -- Drug therapy ,Dexamethasone -- Adverse and side effects ,Drug resistance in microorganisms -- Analysis ,Penicillin -- Evaluation ,Ceftriaxone -- Evaluation - Abstract
Dexamethasone may increase the risk of complications in the treatment of pneumococcal meningitis in children. Researchers reviewed the outcomes of 180 children with pneumococcal meningitis treated in eight hospitals. Fourteen children died, but not due to the failure of antibiotic therapy in the presence of drug-resistant bacteria. One-fourth of children developed motor deficits, and 32% developed a moderate or severe hearing loss during hospitalization. Dexamethasone therapy doubled the risk of hearing loss and substantially increased the risk of developing motor deficits., Objectives. To evaluate the antibiotic susceptibility of Streptococcus pneumoniae isolates obtained from the blood and cerebrospinal fluid of children with meningitis. To describe and compare the clinical and microbiological characteristics, treatment, and outcome of children with meningitis caused by S pneumoniae based on antimicrobial susceptibility of isolates and the administration of dexamethasone. Design and Patients. Children with pneumococcal meningitis were identified from among a group of patients with systemic infections caused by S pneumoniae who were enrolled prospectively in the United States Pediatric Multicenter Pneumococcal Surveillance Study at eight children's hospitals in the United States. From September 1, 1993 to August 31, 1996, 180 children with 181 episodes of pneumococcal meningitis were identified and data were collected by retrospective chart review. Outcome. Clinical and laboratory characteristics were assessed. All pneumococcal isolates were serotyped and antibiotic susceptibilities for penicillin and ceftriaxone were determined. Clinical presentation, hospital course, and outcome parameters at discharge were compared between children infected with penicillin-susceptible isolates and those with nonsusceptible isolates and for children who did and did not receive dexamethasone. Results. Fourteen (7.7%) of 180 children died; none of the fatalities were because of a documented failure of treatment caused by a resistant strain. Only 1 child, who had mastoiditis and a lymphangioma, experienced a bacteriologic failure with a penicillin-resistant (minimum inhibitory concentration = 2 [micro] g/mL) organism. Of the 166 surviving children, 41 (25%) developed neurologic sequelae (motor deficits) and 48 (32%) of 151 children had unilateral (n = 26) or bilateral (n = 22) moderate to severe hearing loss at discharge. Overall, 12.7% and 6.6% of the pneumococcal isolates were intermediate and resistant to penicillin and 4.4% and 2.8% were intermediate and resistant to ceftriaxone, respectively. Clinical presentation, cerebrospinal fluid indices on admission, and hospital course, morbidity, and mortality rates were similar for patients infected with penicillin- or ceftriaxone-susceptible versus nonsusceptible organisms. However, the relatively small numbers of nonsusceptible isolates and the inclusion of vancomycin in the treatment regimen for the majority of the patients limit the power of this study to detect significant differences in outcome between patients infected with susceptible and nonsusceptible isolates. Nonetheless, our results show that the nonsusceptible organisms do not seem to be intrinsically more virulent. Forty children (22%) received dexamethasone ([is greater than or equal to] 8 doses) initiated before or within 1 hour after the first dose of antibiotics. The incidence of any moderate or severe hearing loss was significantly higher in the dexamethasone group (46%) compared with children not receiving any dexamethasone (23%). The incidence of any neurologic deficits, including hearing loss, also was significantly higher in the dexamethasone group (55% vs 33%). However, children in the dexamethasone group more frequently required intubation and mechanical ventilation and had lower initial concentration of glucose in the cerebrospinal fluid than children who did not receive any dexamethasone. When we controlled for the confounding factor, severity of illness (intubation), the incidence of any deafness and of any neurologic sequelae, including deafness, were no longer significantly different between children who did or did not receive dexamethasone. Conclusions. Children with pneumococcal meningitis caused by penicillin- or ceftriaxone-nonsusceptible organisms and those infected by susceptible strains had similar clinical presentation and outcome. The use of dexamethasone was not associated with a beneficial effect in this retrospective and nonrandomized study. Only a well-designed, prospective, randomized, placebo-controlled study, conducted in centers where optimal supportive care can be provided, will determine the potential benefit, if any, of dexamethasone in patients with pneumococcal meningitis. Pediatrics 1998;102:1087-1097; meningitis, Streptococcus pneumoniae, deafness, dexamethasone, antibiotic resistance., ABBREVIATIONS. CSF, cerebrospinal fluid; Hib, Haemophilus influenzae type b; MIC, minimum inhibitory concentration; COID, AAP Committee on Infectious Diseases; CNS, central nervous system. Meningitis caused by Streptococcus pneumoniae is associated [...]
- Published
- 1998
11. Three-year multicenter surveillance of systemic pneumococcal infections in children
- Author
-
Kaplan, Sheldon L., Mason, Edward O., Jr., Barson, William J., Wald, Ellen R., Arditi, Moshe, Tan, Tina Q., Schutze, Gordon E., Bradley, John S., Givner, Laurence B., Kim, Kwang Sik, and Yogev, Ram
- Subjects
Streptococcus pneumoniae ,Streptococcal infections -- Drug therapy ,Drug resistance in microorganisms -- Statistics - Abstract
Physicians should monitor drug resistance in the bacterium Streptococcus pneumoniae so they can change treatment plans accordingly. Researchers tracked antibiotic resistance in 1,255 who were infected with the bacterium over a three-year period. By the end of the period, the number of bacterial isolates that were not susceptible to penicillin or ceftriaxone had doubled. Twenty-one percent were not susceptible to penicillin and 9% were not susceptible to ceftriaxone. Most of the children recovered, even those with bacteria not susceptible to the two antibiotics., Objective. To track antibiotic susceptibility of Streptococcus pneumoniae isolates obtained from children with systemic infections and determine outcome of treatment. Design. A 3-year (September 1993 through August 1996) prospective surveillance study of all invasive pneumococcal infections in children. Patients. Infants and children cared for at eight children's hospitals in the United States with culture-proven systemic pneumococcal infection. Results. One thousand two hundred ninety-one episodes of systemic pneumococcal infection were identified in 1255 children. An underlying illness was present in the children for 27% of the episodes. The proportion of isolates that were nonsusceptible to penicillin or ceftriaxone increased annually and nearly doubled throughout the 3-year period; for the last year the percentages of isolates nonsusceptible to penicillin and ceftriaxone were 21% and 9.3%, respectively. There was no difference in mortality between patients with penicillin-susceptible or nonsusceptible isolates. Only 1 of 742 patients with bacteremia had a repeat blood culture that was positive [is greater than] 1 day after therapy was started. All 24 normal children with bacteremia attributable to isolates resistant to penicillin had resolution of their infection; the most common treatment regimen was a single dose of ceftriaxone followed by an oral antibiotic. Conclusions. The percentage of pneumococcal isolates nonsusceptible to penicillin and ceftriaxone increased yearly among strains recovered from children with systemic infection. Because empiric antibiotic therapy already has changed for suspected pneumococcal infections, antibiotic resistance has not been associated with increased mortality. Careful monitoring of antibiotic susceptibility and outcome of therapy is necessary to continually reassess current recommendations for treatment. Pediatrics 1998;102:538-545; Streptococcus pneumoniae, antibiotic resistance, outcome., ABBREVIATIONS. MIC, minimal inhibitory concentration; CSF, cerebrospinal fluid; CDC, Centers for Disease Control and Prevention. During the past several years in the United States, as well as worldwide, isolates of [...]
- Published
- 1998
12. Natural History of Neonatal Herpes Simplex Virus Infections in the Acyclovir Era
- Author
-
Kimberlin, David W., Lin, Chin-Yu, Jacobs, Richard F., Powell, Dwight A., Frenkel, Lisa M., Gruber, William C., Rathore, Mobeen, Bradley, John S., Diaz, Pamela S., Kumar, Mary, Arvin, Ann M., Gutierrez, Kathleen, Shelton, Mark, Weiner, Leonard B., Sleasman, John W., de Sierra, Teresa Murguía, Soong, Seng-Jaw, Kiell, Jan, Lakeman, Fred D., and Whitley, Richard J.
- Published
- 2001
13. Safety and Efficacy of High-Dose Intravenous Acyclovir in the Management of Neonatal Herpes Simplex Virus Infections
- Author
-
Kimberlin, David W., Lin, Chin-Yu, Jacobs, Richard F., Powell, Dwight A., Corey, Lawrence, Gruber, William C., Rathore, Mobeen, Bradley, John S., Diaz, Pamela S., Kumar, Mary, Arvin, Ann M., Gutierrez, Kathleen, Shelton, Mark, Weiner, Leonard B., Sleasman, John W., de Sierra, Teresa Murguía, Weller, Stephen, Soong, Seng-Jaw, Kiell, Jan, Lakeman, Fred D., and Whitley, Richard J.
- Published
- 2001
14. Pneumococcal Facial Cellulitis in Children
- Author
-
Givner, Laurence B., Mason, Edward O., Jr, Barson, William J., Tan, Tina Q., Wald, Ellen R., Schutze, Gordon E., Kim, Kwang Sik, Bradley, John S., Yogev, Ram, and Kaplan, Sheldon L.
- Published
- 2000
15. Pneumococcal Mastoiditis in Children
- Author
-
Kaplan, Sheldon L., Mason, Edward O., Jr, Wald, Ellen R., Kim, Kwang Sik, Givner, Laurence B., Bradley, John S., Barson, William J., Tan, Tina Q., Schutze, Gordon E., and Yogev, Ram
- Published
- 2000
16. Invasive Pneumococcal Disease in Children’s Hospitals: 2014–2017
- Author
-
Kaplan, Sheldon L., primary, Barson, William J., additional, Lin, Philana Ling, additional, Romero, José R., additional, Bradley, John S., additional, Tan, Tina Q., additional, Pannaraj, Pia S., additional, Givner, Laurence B., additional, and Hulten, Kristina G., additional
- Published
- 2019
- Full Text
- View/download PDF
17. Effectiveness of RSV-IG in Premature Infants: Potential Pitfalls in Clinical Settings
- Author
-
Seid, Michael, Kurtin, Paul S., Romanowski, Gale L., Wozniak, Paul R., Wenger, Steve, Segota, Stacey L., Bradley, John, and Chan, Anita
- Published
- 1998
18. Investigator barriers to pediatric clinical trial enrollment: Findings and recommendations from the Clinical Trials Transformation Initiative
- Author
-
Smith, Brian, primary, Benjamin, Danny, additional, Bradley, John, additional, Greenberg, Rachel, additional, Noel, Gary, additional, Tiernan, Rose, additional, Wheeler, Chris, additional, and Corneli, Amy, additional
- Published
- 2018
- Full Text
- View/download PDF
19. Obstacles to Pediatric Clinical Trial Enrollment: Why Parents Refuse; Findings from the Clinical Trials Transformation Initiative
- Author
-
Smith, Brian, primary, Bradley, John, additional, Benjamin, Danny, additional, Noel, Gary, additional, Greenberg, Rachel, additional, Gamel, Breck, additional, Bloom, Diane, additional, Tiernan, Rose, additional, and Wheeler, Chris, additional
- Published
- 2018
- Full Text
- View/download PDF
20. Intravenous Zanamivir in Hospitalized Patients With Influenza
- Author
-
Bradley, John S., primary, Blumer, Jeffrey L., additional, Romero, José R., additional, Michaels, Marian G., additional, Munoz, Flor M., additional, Kimberlin, David W., additional, Pahud, Barbara, additional, DeBiasi, Roberta L., additional, Yamamoto, Go, additional, Roberts, Grace, additional, Hossain, Mohammad, additional, Shortino, Denise, additional, Yates, Phillip J., additional, Adams, Bryan, additional, and Peppercorn, Amanda, additional
- Published
- 2017
- Full Text
- View/download PDF
21. Daptomycin for Complicated Skin Infections: A Randomized Trial
- Author
-
Bradley, John, primary, Glasser, Chad, additional, Patino, Hernando, additional, Arnold, Sandra R., additional, Arrieta, Antonio, additional, Congeni, Blaise, additional, Daum, Robert S., additional, Kojaoghlanian, Tsoline, additional, Yoon, Minjung, additional, Anastasiou, Diane, additional, Wolf, Dominik J., additional, and Bokesch, Paula, additional
- Published
- 2017
- Full Text
- View/download PDF
22. Assessment of Musculoskeletal Toxicity 5 Years After Therapy With Levofloxacin
- Author
-
Bradley, John S., primary, Kauffman, Ralph E., additional, Balis, Dainius A., additional, Duffy, Ciaran M., additional, Gerbino, Peter G., additional, Maldonado, Samuel D., additional, and Noel, Gary J., additional
- Published
- 2014
- Full Text
- View/download PDF
23. Acute Bacterial Osteoarticular Infections: Eight-Year Analysis of C-Reactive Protein for Oral Step-Down Therapy
- Author
-
Arnold, John C., primary, Cannavino, Christopher R., additional, Ross, Mindy K., additional, Westley, Ben, additional, Miller, Thomas C., additional, Riffenburgh, Robert H., additional, and Bradley, John, additional
- Published
- 2012
- Full Text
- View/download PDF
24. Linezolid-Associated Peripheral and Optic Neuropathy in Children
- Author
-
Nambiar, Sumathi, primary, Rellosa, Neil, additional, Wassel, Ronald T., additional, Borders-Hemphill, Vicky, additional, and Bradley, John S., additional
- Published
- 2011
- Full Text
- View/download PDF
25. Intravenous Ceftriaxone and Calcium in the Neonate: Assessing the Risk for Cardiopulmonary Adverse Events
- Author
-
Bradley, John S., primary, Wassel, Ronald T., additional, Lee, Lucia, additional, and Nambiar, Sumathi, additional
- Published
- 2009
- Full Text
- View/download PDF
26. Clinical Characteristics and Outcome of Children With Pneumonia Attributable to Penicillin-susceptible and Penicillin-nonsusceptibleStreptococcus pneumoniae
- Author
-
Tan, Tina Q., primary, Mason, Edward O., additional, Barson, William J., additional, Wald, Ellen R., additional, Schutze, Gordon E., additional, Bradley, John S., additional, Arditi, Moshe, additional, Givner, Laurence B., additional, Yogev, Ram, additional, Kim, Kwang Sik, additional, and Kaplan, Sheldon L., additional
- Published
- 1998
- Full Text
- View/download PDF
27. Pediatric Anthrax Clinical Management: Executive Summary.
- Author
-
Bradley, John S., Peacock, Georgina, Krug, Steven E., Bower, William A., Cohn, Amanda C., Meaney-Delman, Dana, and Pavia, Andrew T.
- Subjects
- *
ANTHRAX treatment , *ADRENOCORTICAL hormones , *ANTHRAX vaccines , *ANTITOXINS , *IMMUNIZATION , *IMMUNOGLOBULINS , *MEDICAL protocols , *PUBLIC health , *BIOTERRORISM , *DRUG administration , *DRUG dosage - Abstract
The article presents a summary of the guidance contained in the clinical report for the diagnosis and management of anthrax including antimicrobial treatment and postexposure prophylaxis (PEP), use of antitoxin and recommendations for the use of anthrax vaccine in children and infants. Topics covered include key considerations in a mass B anthracis exposure scenario such as determining the presence and extent of a bioterror event and management of children during an anthrax bioterror event.
- Published
- 2014
- Full Text
- View/download PDF
28. The Potentially Suicidal Student in the School Setting.
- Author
-
Ushkow, Martin C., Asbury, John R., Bradford, Bradley John, Nader, Philip R., Poole, Steven R., Worthington, Daniel Charles, Elster, Arthur B., Haines, Vivian, Jung, Paul W., Lachelt, Patricia, Legako, R. Dee, Santelli, John, and Williams, James H.
- Published
- 1990
29. Lumbar Punctures and Meningitis.
- Author
-
Kvalsvig, A. J., Unsworth, D. J., Arkava, Todd, Luszczak, Michael, Kanegaye, John T., and Bradley, John S.
- Published
- 2002
- Full Text
- View/download PDF
30. The use of systemic and topical fluoroquinolones.
- Author
-
Bradley JS and Jackson MA
- Subjects
- Administration, Oral, Administration, Topical, Animals, Anti-Bacterial Agents adverse effects, Drug Resistance, Bacterial, Fluoroquinolones adverse effects, Humans, Anti-Bacterial Agents therapeutic use, Bacterial Infections drug therapy, Fluoroquinolones therapeutic use
- Abstract
Appropriate prescribing practices for fluoroquinolones are essential as evolving resistance patterns are considered, additional treatment indications are identified, and the toxicity profile of fluoroquinolones in children becomes better defined. Earlier recommendations for systemic therapy remain; expanded uses of fluoroquinolones for the treatment of certain infections are outlined in this report. Although fluoroquinolones are reasonably safe in children, clinicians should be aware of the specific adverse reactions. Use of fluoroquinolones in children should continue to be limited to treatment of infections for which no safe and effective alternative exists.
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.